V.TLT
|
Just listened to part 2 Kolelin interview w/ Roger White. (1) Roger asked...
|
V.TLT
|
and if we were evaluating gene therapy then it would make a difference...
|
V.TLT
|
There is no longer an open question on financing. I was out from late...
|
V.TLT
|
fairweather, No problem. I have convinced myself that this technology will...
|
V.TLT
|
So, a week or so ago, a poster indicated that he had spoken with TLT IR and...
|
V.TLT
|
Oxygen has been mentioned throughout Theralase reporting as being generated...
|
V.TLT
|
Good post. Thanks! You'll note that none of these are a complete cure...
|
V.TLT
|
bencro, I believe that there is a near unanimous feeling on this board that...
|
V.TLT
|
bencro, I started posting here just under 2 months ago. Several of my posts...
|
V.TLT
|
fair weather, Thank you for clairifying.If White told you that then all that...
|
V.TLT
|
fairweather1, Regarding your comment, "of course, CEO told me they won...
|
V.TLT
|
"Can anyone tell me what it takes to move to another exchange?"...
|
V.TLT
|
Your comment, "just gotta exceed median survival with good safety during...
|
V.TLT
|
There are two points here: (1) Whatever leasing arrangements are made...
|
V.TLT
|
In today's news release and a closing sentence by White, he continues to...
|
V.TLT
|
A couple of points from this $8 million study: 1.) as stated in the article...
|
V.TLT
|
bencro, Another excellent job of resurrecting past trials related to TLT...
|
V.TLT
|
today partly, Thanks for posting this article. Theres that mention of...
|
V.TLT
|
I'm not sue I understand how ODD would improve potential approval time...
|
V.TLT
|
HD8888, Listen, if you want to talk about ODD in pre- clinical trials or...
|